- Home
- DNTH vs UTI Comparison
DNTH vs UTI Comparison
Compare DNTH & UTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DNTH | UTI |
|---|---|---|
| Founded | 2015 | 1965 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.5B |
| IPO Year | 2018 | 2003 |
Fundamental Metrics
Financial Performance| Metric | DNTH | UTI |
|---|---|---|
| Price | $53.87 | $34.54 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 4 |
| Target Price | ★ $71.22 | $37.50 |
| AVG Volume (30 Days) | 698.2K | ★ 871.6K |
| Earning Date | 04-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 69.82 | 50.67 |
| EPS | N/A | ★ 0.23 |
| Revenue | $6,235,000.00 | ★ $835,616,000.00 |
| Revenue This Year | N/A | $10.16 |
| Revenue Next Year | N/A | $8.21 |
| P/E Ratio | ★ N/A | $151.65 |
| Revenue Growth | ★ 120.63 | 14.05 |
| 52 Week Low | $13.37 | $21.29 |
| 52 Week High | $57.50 | $36.32 |
Technical Indicators
Market Signals| Indicator | DNTH | UTI |
|---|---|---|
| Relative Strength Index (RSI) | 60.72 | 71.23 |
| Support Level | $33.94 | $30.22 |
| Resistance Level | $57.50 | $35.68 |
| Average True Range (ATR) | 3.08 | 1.60 |
| MACD | 0.12 | 0.66 |
| Stochastic Oscillator | 92.21 | 93.07 |
Price Performance
Historical ComparisonAbout DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About UTI Universal Technical Institute Inc
Universal Technical Institute Inc is an educational institution. It provides undergraduate degree, as well as certificate programs for technicians in the automotive, diesel, collision repair, motorcycle and marine fields. The company's reportable segment which includes Universal Technical Institute (UTI) and Concorde Career Colleges, Corporate. Majority of the revenue is generated from UTI segment which provides different kinds of degree and non-degree transportation and skilled trades technical training programs under brands such as Universal Technical Institute, Motorcycle Mechanics Institute, Marine Mechanics Institute and others. It also provides dealer technician training or instructor staffing services to manufacturers.